SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:lnu-111261"
 

Search: onr:"swepub:oai:DiVA.org:lnu-111261" > Trends, geographica...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Trends, geographical variation and factors associated with the use of anti-VEGF intravitreal injections in Portugal (2013–2018): a retrospective analysis of administrative data

Rocha, João Victor (author)
NOVA University Lisbon, Portugal
Marques, Ana Patricia (author)
NOVA University Lisbon, Portugal
Macedo, António Filipe, Senior Lecturer, 1976- (author)
Linnéuniversitetet,Institutionen för medicin och optometri (MEO),Hållbar hälsa
show more...
Afonso-Silva, Marta (author)
Novartis Farma Produtos Farmacêuticos SA, Portugal
Laires, Pedro (author)
NOVA University Lisbon, Portugal;Novartis Farma Produtos Farmacêuticos SA, Portugal
Almeida, Ana Sofia (author)
Novartis Farma Produtos Farmacêuticos SA, Portugal
Fernandes, Julieta (author)
Novartis Farma Produtos Farmacêuticos SA, Portugal
Pardal, Marisa (author)
Novartis Farma Produtos Farmacêuticos SA, Portugal
Santana, Rui (author)
NOVA University Lisbon, Portugal
show less...
 (creator_code:org_t)
2022-04-06
2022
English.
In: BMJ Open. - : BMJ Publishing Group Ltd. - 2044-6055. ; 12:4
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Aims The arrival of anti-vascular endothelial growth factor (anti-VEGF) therapies represented a treatment shift for several ophthalmological disorders and led to an increasing number of patients undergoing intravitreal injections. The aims of this observational study were to assess the expansion of anti-VEGF intravitreal injections in the Portuguese National Health System (NHS) and to identify factors correlated with geographical variations in episode rates.Methods Administrative database on discharge from Portuguese NHS hospitals was analysed for annual values and rates of intravitreal anti-VEGF injections at a national and regional level, between 2013 and 2018.Results The number of episodes of anti-VEGF treatment and patients treated increased 16% and 9% per year, respectively, between 2013 and 2018. During the study period around 72% of patients were treated in the Metropolitan areas of Lisbon and Porto and in the Central region. Intravitreal anti-VEGF treatment rates in 2018 were 560 per 100 000 population and presented high variability between municipalities. Higher anti-VEGF treatment rates at the municipality level were associated with shorter distances between their residence and the hospital. At the hospital level, higher ratio of ophthalmologists and higher organisational level were associated with higher anti-VEGF treatment rates.Conclusion The number of episodes and patients treated with anti-VEGF injections has been growing in recent years. Proximity to healthcare, more access to ophthalmologists and hospitals with higher organisational levels are associated with higher anti-VEGF treatment rates. Improving access is crucial to reduce regional discrepancies and ensure optimal treatment frequency, which may improve health outcomes.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Oftalmologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Ophthalmology (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Annan medicin och hälsovetenskap -- Övrig annan medicin och hälsovetenskap (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Other Medical and Health Sciences -- Other Medical and Health Sciences not elsewhere specified (hsv//eng)

Keyword

Proliferative diabetic retinopathy
Retinal oedema
Choroidal neovascularisation
Retinal vein occlusion
anti-VEGF intravitreal injections
Neovascular age-related macular degeneration
Diabetic macular oedema
Optometry
Optometri
Medicin
Medicine

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

  • BMJ Open (Search for host publication in LIBRIS)

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view